{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:48:33Z","timestamp":1791348513536,"version":"4.3.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.vaccine.2009.01.125","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T10:52:28Z","timestamp":1234003948000},"page":"2114-2120","source":"Crossref","is-referenced-by-count":151,"title":["Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring"],"prefix":"10.1016","volume":"27","author":[{"given":"Claudia","family":"Vellozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale R.","family":"Burwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azra","family":"Dobardzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimp","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penina","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (1)","key":"10.1016\/j.vaccine.2009.01.125_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14760584.7.1.75","article-title":"Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience","volume":"7","author":"Iskander","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.125_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"RR-6","key":"10.1016\/j.vaccine.2009.01.125_bib3","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007","volume":"56","author":"Fiore","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2009.01.125_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.01.125_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza a (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.01.125_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.125_bib7","first-page":"10","article-title":"The complicated task of monitoring vaccine safety","volume":"112","author":"Ellenberg","year":"1997","journal-title":"Public Health Rep"},{"key":"10.1016\/j.vaccine.2009.01.125_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2009.01.125_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3928\/0090-4481-20040901-11","article-title":"The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety","volume":"33","author":"Iskander","year":"2004","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.vaccine.2009.01.125_bib10","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","author":"Zhou","year":"2003","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2009.01.125_bib11","series-title":"COSTART: coding symbol for thesaurus of adverse reaction terms","year":"1989"},{"key":"10.1016\/j.vaccine.2009.01.125_bib12","unstructured":"Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences: Federal Register; 1997, p. 52252\u201353."},{"key":"10.1016\/j.vaccine.2009.01.125_bib13","unstructured":"Centers for Disease Control and Prevention NCHS. National Health Interview Survey Datasets, Available from: http:\/\/www.cdc.gov\/nchs\/about\/major\/nhis\/quest_data_related_doc.htm; 2008 [cited 2009 January 15, 2009]."},{"key":"10.1016\/j.vaccine.2009.01.125_bib14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.vaccine.2008.01.040","article-title":"Influenza vaccination of recommended adult populations, U.S., 1989\u20132005.","volume":"26","author":"Lu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.125_bib15","unstructured":"Massey JT, Moore TF, Parsons VL, Tadros W. National health interview survey, 1985\u20131994: design and estimation. Vital and health statistics, Series 2: data evaluation and methods research. No. 110. Public Health Service, DHHS; 1989."},{"key":"10.1016\/j.vaccine.2009.01.125_bib16","unstructured":"United States Government Census Report, Available from: http:\/\/www.census.gov; 2000 [cited April 8, 2008]."},{"key":"10.1016\/j.vaccine.2009.01.125_bib17","series-title":"Immunization safety review. Influenza vaccines and neurological complications","author":"Institute of Medicine (IOM)","year":"2004"},{"key":"10.1016\/j.vaccine.2009.01.125_bib18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.158.16.1769","article-title":"Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens","volume":"158","author":"Nichol","year":"1998","journal-title":"Arch Int Med"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.01.125_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.1107","article-title":"Comparing data mining methods on the VAERS database","volume":"14","author":"Banks","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2009.01.125_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use if proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2009.01.125_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2165\/00002018-200831080-00003","article-title":"Effects of stratification on data mining in the Vaccine Adverse Event Reporting System (VAERS)","volume":"31","author":"Woo","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2009.01.125_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/2686093","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Statistician"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.125_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2009.01.125_bib24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.31.8.966","article-title":"Acute transverse myelitis: incidence and etiologic considerations","volume":"31","author":"Berman","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2009.01.125_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1993.00540050074019","article-title":"Transverse myelitis: retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events","volume":"50","author":"Jeffery","year":"1993","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib26","first-page":"1183","article-title":"Updated interim influenza vaccination recommendations\u20142004-05 influenza season","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.vaccine.2009.01.125_bib27","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barre syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.01.125_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"issue":"25","key":"10.1016\/j.vaccine.2009.01.125_bib29","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992-93 and 1993-94 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.125_bib30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.248.6.698","article-title":"Guillain-Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981. Lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.vaccine.2009.01.125_bib31","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain-Barre syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.01.125_bib32","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain-Barr\u00e9 Syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2009.01.125_bib33","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 Syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Int Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.01.125_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2009.01.125_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/hv.2790","article-title":"Bell's palsy and parenteral inactivated influenza vaccine","volume":"2","author":"Stowe","year":"2006","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.125_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00006454-200102000-00022","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the Vaccine Adverse Event Reporting System","volume":"20","author":"Ball","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"ACS-1","key":"10.1016\/j.vaccine.2009.01.125_bib37","first-page":"1","article-title":"National Advisory Committee on Immunization (NACI), Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000\u20132001 influenza season","volume":"27","author":"King","year":"2001","journal-title":"Can Commun Dis Rep"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2009.01.125_bib38","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/S0264-410X(03)00095-1","article-title":"Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine","volume":"21","author":"DeSerres","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.01.125_bib39","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1016\/j.vaccine.2005.01.154","article-title":"Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons","volume":"23","author":"DeSerres","year":"2005","journal-title":"Vaccine"},{"issue":"ACS-6","key":"10.1016\/j.vaccine.2009.01.125_bib40","first-page":"1","article-title":"Supplementary statement for the 2002\u20132003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination","volume":"28","author":"National Advisory Committee on Immunization (NACI)","year":"2002","journal-title":"Can Commun Dis Rep"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.125_bib41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/368189","article-title":"Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults","volume":"36","author":"Scheifele","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"August (19)","key":"10.1016\/j.vaccine.2009.01.125_bib42","first-page":"1","article-title":"Deaths: final data for 2004","volume":"55","author":"Minino","year":"2007","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.vaccine.2009.01.125_bib43","doi-asserted-by":"crossref","first-page":"S652","DOI":"10.1093\/infdis\/136.Supplement_3.S652","article-title":"Safety of influenza vaccination in allergic children","volume":"136","author":"Bierman","year":"1977","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2009.01.125_bib44","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.271.20.1602","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella: summary of a report from the Institute of Medicine (IOM)","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.01.125_bib45","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/BF02243011","article-title":"A case of reactive arthritis after influenza vaccination","volume":"13","author":"Biasi","year":"1994","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib46","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/clinids\/19.5.979","article-title":"Development of uveitis following vaccination for influenza","volume":"19","author":"Blanche","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.01.125_bib47","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1176\/ajp.150.12.1899a","article-title":"Delirium following influenza vaccination","volume":"150","author":"Boutros","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.vaccine.2009.01.125_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.1998.02097.x","article-title":"Does influenza vaccination induce bullous pemphigoid? A report of four cases","volume":"138","author":"Downs","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib49","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/archinte.161.7.1008-a","article-title":"Cavernous sinus syndrome due to vaccination-induced giant cell arteritis","volume":"161","author":"Finsterer","year":"2001","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2009.01.125_bib50","first-page":"463","article-title":"Influenza vaccine may enhance theophylline toxicity. A case report and review of the literature","volume":"88","author":"Hamdy","year":"1995","journal-title":"J Tenn Med Assoc"},{"key":"10.1016\/j.vaccine.2009.01.125_bib51","first-page":"1198","article-title":"Microscopic polyangiitis after influenza vaccination","volume":"24","author":"Kelsall","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib52","first-page":"246","article-title":"Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination","volume":"54","author":"Kielstein","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib53","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/jgs.2000.48.11.1533a","article-title":"Polymyalgia rheumatica following influenza vaccination","volume":"48","author":"Liozon","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2009.01.125_bib54","first-page":"1429","article-title":"Systemic vasculitis following influenza vaccination\u2014report of 3 cases and literature review","volume":"20","author":"Mader","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib55","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1532-5415.2004.52379_11.x","article-title":"Polymyalgia rheumatica complicating influenza vaccination","volume":"52","author":"Marti","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2009.01.125_bib56","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2005.04.036","article-title":"Cutaneous lymphoid hyperplasia and marginal zone B-cell lymphoma following vaccination","volume":"53","author":"May","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib57","first-page":"587","article-title":"Thrombotic thrombocytopenic purpura following influenza vaccination\u2014a brief case report","volume":"62","author":"Ramakrishnan","year":"1998","journal-title":"Conn Med"},{"key":"10.1016\/j.vaccine.2009.01.125_bib58","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0002-9394(14)70638-5","article-title":"Bilateral simultaneous corneal graft rejection after influenza vaccination","volume":"121","author":"Solomon","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2230.2003.01188.x","article-title":"Leukocytoclastic vasculitis and influenza vaccination","volume":"28","author":"Tavadia","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.vaccine.2009.01.125_bib60","first-page":"322","article-title":"Immune thrombocytopenic purpura following influenza vaccination","volume":"8","author":"Tishler","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2009.01.125_bib61","first-page":"1120","article-title":"Update: Guillain-Barr\u00e9 Syndrome among recipients of Menactra\u00ae meningococcal conjugate vaccine\u2014United States, June 2005\u2013September 2006","year":"2006","journal-title":"Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.125_bib62","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.1542\/peds.107.6.e97","article-title":"Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system","volume":"107","author":"Zanardi","year":"2001","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T21:53:50Z","timestamp":1558130030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":62,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0264410X09002047"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.125","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}